LTR Pharma
ASX:LTP
LTR Pharma is a Clinical Stage Biopharmaceutical Company
Featured Articles and Interviews
More Featured Articles and Inverviews
Press Releases
More Press Releases
LTR Pharma is commercialising a ‘First in Class’ rapid treatment for Erectile Dysfunction (ED) SPONTAN® with fast-track US NDA Filing within two years
Interactive Chart
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.